Treating fatty liver disease by modulating mitochondrial pyruvate metabolism

Jerry R. Colca, William G. McDonald, Kyle McCommis, Brian N. Finck

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This commentary suggests treating nonalcoholic steatohepatitis through a newly identified mechanism consistent with pathophysiology. (Hepatology Communications 2017;1:193-197).

Original languageEnglish
Pages (from-to)193-197
Number of pages5
JournalHepatology Communications
Volume1
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Dive into the research topics of 'Treating fatty liver disease by modulating mitochondrial pyruvate metabolism'. Together they form a unique fingerprint.

Cite this